Arkolith/Insider Trading/AVTE/Form 4

Gillies Hunter

CHIEF MEDICAL OFFICERAerovate Therapeutics, Inc. (AVTE) · full profile →Form 4 · filed Mar 20, 2024
Net Selling
Open-Market Buys
$0
Open-Market Sells
$181K
Net Open-Market Flow
-$181K
Transactions
6
4 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 18, 2024Sell(S)6K$25.81$165K4K
Mar 18, 2024Option exercise(M)3K$2.14$6K10K
Mar 18, 2024Option exercise(M)4K$1.74$7K7K
Mar 18, 2024Sell(S)613$26.40$16K3K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Mar 18, 2024Option exercise(M)4K—$04K
Mar 18, 2024Option exercise(M)3K—$099K

Transaction Codes

S
Open-market sale
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001415889-24-008771) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML